Stay updated on BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial
Sign up to get notified when there's something new on the BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial page.

Latest updates to the BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision updated to v3.4.2; the older government-funding notice (v3.4.1) and its operating-status messaging were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and guidance to status updates. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check28 days agoChange DetectedThe page now includes a glossary toggle and updated QC metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). The previous version displayed Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page now displays a new revision line 'Revision: v3.3.4' and removes the previous 'Revision: v3.3.3'; no other content appears to be affected.SummaryDifference0.0%

- Check63 days agoChange DetectedExpanded the Study Locations section to include numerous US states and international sites (e.g., Fukuoka, Kanagawa, Nara, Tokyo) and updated the revision to v3.3.3.SummaryDifference1%

- Check92 days agoChange DetectedPublications sourcing note updated: it now states that publications are automatically filled in from PubMed and may not all be about the study, replacing the previous wording that said publications come from PubMed and are automatically created by ClinicalTrials.gov using the NCT number; Revision changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial page.